Mezagitamab (TAK-079), an IgG1lambda anti-CD38 monoclonal antibody, functions by depleting tumor cells that express CD38 through both antibody and complement-dependent cytotoxicity. It shows potential for use in the treatment of relapsed/refractory multiple m
CAS Number:
[2227490-52-8]
* VAT and and shipping costs not included. Errors and price changes excepted